Education
About Us
Working with TipRanks
Follow Us
STELLA PHARMA CORPORATION (JP:4888)
:4888
4888 Stock Chart & Stats
¥223.00
-¥14.00(-2.68%)
At close: 4:00 PM EST
¥223.00
-¥14.00(-2.68%)
Day’s Range― - ―
52-Week Range¥223.00 - ¥565.00
Previous CloseN/A
Volume163.70K
Average Volume (3M)332.29K
Market Cap
¥7.59B
Enterprise Value¥11.69B
Total Cash (Recent Filing)¥2.85B
Total Debt (Recent Filing)¥727.12M
Price to Earnings (P/E)―
Beta0.93
Next Earnings
Feb 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.45
Shares Outstanding34,034,100
10 Day Avg. Volume566,500
30 Day Avg. Volume332,290
Financial Highlights & Ratios
PEG Ratio1.10
Price to Book (P/B)3.99
Price to Sales (P/S)13.30
P/FCF Ratio93.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
4888 FAQ
What was STELLA PHARMA CORPORATION’s price range in the past 12 months?
STELLA PHARMA CORPORATION lowest stock price was ¥223.00 and its highest was ¥565.00 in the past 12 months.
What is STELLA PHARMA CORPORATION’s market cap?
STELLA PHARMA CORPORATION’s market cap is ¥7.59B.
When is STELLA PHARMA CORPORATION’s upcoming earnings report date?
STELLA PHARMA CORPORATION’s upcoming earnings report date is Feb 06, 2026 which is in 44 days.
How were STELLA PHARMA CORPORATION’s earnings last quarter?
STELLA PHARMA CORPORATION released its earnings results on Nov 13, 2025. The company reported -¥4.45 earnings per share for the quarter, missing the consensus estimate of N/A by -¥4.45.
Is STELLA PHARMA CORPORATION overvalued?
According to Wall Street analysts STELLA PHARMA CORPORATION’s price is currently Overvalued.
Does STELLA PHARMA CORPORATION pay dividends?
STELLA PHARMA CORPORATION does not currently pay dividends.
What is STELLA PHARMA CORPORATION’s EPS estimate?
STELLA PHARMA CORPORATION’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does STELLA PHARMA CORPORATION have?
STELLA PHARMA CORPORATION has 34,034,100 shares outstanding.
What happened to STELLA PHARMA CORPORATION’s price movement after its last earnings report?
STELLA PHARMA CORPORATION reported an EPS of -¥4.45 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.667%.
Which hedge fund is a major shareholder of STELLA PHARMA CORPORATION?
Currently, no hedge funds are holding shares in JP:4888
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
STELLA PHARMA CORPORATION
STELLA PHARMA CORPORATION (4888) is a biotechnology company focused on developing innovative pharmaceutical products aimed at addressing critical healthcare needs. The company operates primarily in the sectors of biotechnology and pharmaceuticals, with a core emphasis on research and development of therapeutics for chronic diseases, including oncology and autoimmune conditions. STELLA PHARMA is dedicated to advancing medical science through its proprietary drug formulations and cutting-edge research methodologies.
Technical Analysis
RaQualia Pharma Inc.
―
Chiome Bioscience Inc.
―
Oncolys BioPharma, Inc.
―
StemRIM Inc.
―
CellSource Co., Ltd.
―
Options Prices
Currently, No data available
---